Medtronic has completed 12 months of follow up in their U.S.-based STOP-AF clinical trial (Sustained Treatment of Paroxysmal Atrial Fibrillation) for treatment of paroxysmal atrial fibrillation. This trial evaluated their cryoballoon catheter, the Arctic Front® CryoAblation Catheter System, which is already approved for use in Europe, Australia and Hong Kong.
Learn more: Medtronic Clinical Trial Evaluating the Industry's First Cryoballoon Technology Designed for Paroxysmal Atrial Fibrillation Completes Follow Up
Mellanie True Hills Bio: https://www.empowher.com/users/mellanie-true-hills
We value and respect our HERWriters' experiences, but everyone is different. Many of our writers are speaking from personal experience, and what's worked for them may not work for you. Their articles are not a substitute for medical advice, although we hope you can gain knowledge from their insight.
Add a CommentComments
There are no comments yet. Be the first one and get the conversation started!